Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by an Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/16/21	$250,000,000	Series A	Boxer Capital BVF Partners Cormorant Asset Management EcoR1 Capital Franklin Templeton General Atlantic Janus Henderson Investors Logos Capital T. Rowe Price Associates Venrock Healthcare Partners Vida Ventures Wellington Management Company	undisclosed